Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent

Anna Do, Elyse McGlumphy, Aakriti Shukla, Sonal Dangda, Joel S. Schuman, Michael V. Boland, Jithin Yohannan, Joseph F. Panarelli, E. Randy Craven

Research output: Contribution to journalArticlepeer-review

Abstract

Purpose: To describe the efficacy and safety of open versus closed conjunctival implantation of the XEN45 Gel Stent (Allergan Inc). Design: Retrospective, multicenter study. Participants: A total of 137 patients with glaucoma who underwent XEN45 implantation via open or closed conjunctival methods. The XEN45 was implanted as a stand-alone procedure or at the time of cataract surgery by 5 surgeons. Methods: Patient demographics, diagnoses, preoperative and postoperative clinical data, outcome measures including intraocular pressure (IOP), use of glaucoma medications, visual acuity, and complications were collected. Statistical analyses were performed with P < 0.05 as significant. Main Outcome Measures: Failure was defined as less than 20% reduction of IOP from medicated baseline or IOP >21 mmHg at 2 consecutive visits at postoperative month 1 and beyond, the need for subsequent operative intervention or additional glaucoma surgery, or a catastrophic event such as loss of light perception. Eyes that had not failed by these criteria and were not on glaucoma medications were considered complete successes. Eyes that had not failed but required glaucoma medications were defined as qualified successes. Results: Complete success was achieved in 31% and 56% of the closed and open groups, respectively (P = 0.01). Qualified success was achieved in 53% and 71% of the closed and open groups, respectively (P = 0.06). At postoperative month 12, the open conjunctiva group was using fewer glaucoma medications than the closed group (0.9 vs. 1.8, respectively; P = 0.02). At postoperative month 12, the open group had a significantly greater percentage of IOP reduction compared with the closed group (43.1% vs. 24.8%, respectively; P = 0.02). Postoperative needling rates were higher in the closed group compared with the open group (36.1% vs. 11.8%, P = 0.001). Conclusions: Implantation of the XEN45 with opening of the conjunctiva is a safe and efficacious procedure to lower IOP with comparable success rate and lower needling rate compared with the closed conjunctiva technique. Prospective evaluation of the various methods for XEN45 implantation will allow for further comparison.

Original languageEnglish (US)
Pages (from-to)343-349
Number of pages7
JournalOphthalmology Glaucoma
Volume4
Issue number4
DOIs
StatePublished - Jul 1 2021

Keywords

  • Gel stent
  • Glaucoma
  • MIGS
  • Minimally invasive glaucoma surgery
  • XEN
  • Cataract Extraction
  • Humans
  • Glaucoma Drainage Implants
  • Treatment Outcome
  • Glaucoma, Open-Angle/surgery
  • Conjunctiva/surgery
  • Stents/adverse effects
  • Retrospective Studies

ASJC Scopus subject areas

  • General Medicine
  • Ophthalmology

Fingerprint

Dive into the research topics of 'Comparison of Clinical Outcomes with Open Versus Closed Conjunctiva Implantation of the XEN45 Gel Stent'. Together they form a unique fingerprint.

Cite this